IMEIK(300896.SZ)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
IMEIK
300896.SZ
Imeik Technology Development Co.,Ltd. engages in the research and development, and transformation of biomedical materials and biopharmaceutical products in China. The company offers aesthetic medicine products, such as cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere; poly facial implant thread; medical sodium hyaluronate-hydroxypropyl methylcellulose gel; sodium hyaluronate composite solution for injection; modified sodium hyaluronate gel for injection; medical PVA gel ball-sodium hyaluronate-hydroxypropyl methylcellulose gel; and skin care products. It serves medical aesthetic institutions.
1.468 T
300896.SZMarket value -Rank by Market Cap -/-

Financial Score

19/05/2026 Update
C
BiotechnologyIndustry
Industry Ranking22/81
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE14.22%B
    • Profit Margin47.28%A
    • Gross Margin92.49%A
  • Growth ScoreD
    • Revenue YoY-15.90%E
    • Net Profit YoY-38.87%D
    • Total Assets YoY4.80%C
    • Net Assets YoY0.74%C
  • Cash ScoreD
    • Cash Flow Margin108.54%C
    • OCF YoY-15.90%E
  • Operating ScoreD
    • Turnover0.27D
  • Debt ScoreA
    • Gearing Ratio7.43%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    IMEIK's revenue in 2025 is 2.45 billion, a year-on-year decrease of 19%, with a net profit of 1.1 billion after deducting non-recurring items, down 41%

    雷帝触网·
    SZ
    300896
    -0.73%
    雷帝触网·
    SZ
    300896
    -0.73%

    National Health Commission: Beauty institutions, hair salons, nail salons, and other lifestyle-related businesses are strictly prohibited from conducting "light medical beauty" projects

    Wallstreetcn·
    SZ
    300896
    -0.73%
    SH
    688366
    +0.06%
    SH
    688363
    +1.19%
    Wallstreetcn·
    SZ
    300896
    -0.73%
    SH
    688366
    +0.06%
    SH
    688363
    +1.19%

    IMEIK: Subsidiary obtains Minoxidil topical solution "Drug Registration Certificate"

    Zhitong·
    SZ
    300896
    -0.73%
    Zhitong·
    SZ
    300896
    -0.73%

    IMEIK has established a technology development company in Tianjin

    Zhitong·
    SZ
    300896
    -0.73%
    Zhitong·
    SZ
    300896
    -0.73%

    IMEIK: Acquisition of controlling stake in South Korea's REGEN Biotech, Inc. has been completed

    Zhitong·
    SZ
    300896
    -0.73%
    Zhitong·
    SZ
    300896
    -0.73%
    © 2026 Longbridge｜Disclaimer